SCHEDULE 13G · 2026-11-13
Zhen Li reports a significant ownership stake in ADARx Pharmaceuticals, reflecting leadership confidence in the company's future.
| Name | ADARx Pharmaceuticals, Inc. |
|---|---|
| CIK | 0001802369 |
| Tickers | ADRX |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 844145188 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 858-283-9472 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Zhen Li reports a significant ownership stake in ADARx Pharmaceuticals, reflecting leadership confidence in the company's future.
51 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001729510-26-000012 | 005-95946 | 261560982 | 34 | 26455 | |||
| 2026-11-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001729510-26-000009 | 005-95946 | 261552654 | 34 | 9542 | |||
| 2026-11-12 | 10-Q | 10-Q | 0001193125-26-458444 | 001-43482 | 261547179 | 34 | 12706288 | 1 | 1 | |
| 2026-11-12 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-458321 | 001-43482 | 261546834 | 34 | 17463259 | 1 | 1 |
| 2026-10-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001764435-26-000003 | 005-95946 | 261466287 | 34 | 22359 | |||
| 2026-10-05 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001072613-26-000820 | 005-95946 | 261441701 | 34 | 179249 | |||
| 2026-10-02 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0000947871-26-000917 | 005-95946 | 261438078 | 34 | 42199 | |||
| 2026-10-01 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-410626 | 005-95946 | 261431202 | 34 | 8205 | |||
| 2026-09-30 | 4 | xslF345X06/ownership.xml | 0000947871-26-000912 | 22989 | ||||||
| 2026-09-30 | 4 | xslF345X06/ownership.xml | 0000947871-26-000911 | 44075 | ||||||
| 2026-09-30 | 4 | xslF345X06/ownership.xml | 0000947871-26-000910 | 51666 | ||||||
| 2026-09-29 | 4 | 4 | 0001193125-26-408064 | 33426 | ||||||
| 2026-09-29 | 4 | 4 | 0001193125-26-408061 | 32944 | ||||||
| 2026-09-29 | 4 | xslF345X06/form4-09302026_010959.xml | 0001231919-26-001406 | 31963 | ||||||
| 2026-09-28 | S-8 | S-8 | 0001193125-26-405447 | 333-299175 | 261417976 | 33 | 249615 | 1 | 1 | |
| 2026-09-28 | 4 | xslF345X06/form4-09282026_040907.xml | 0002153958-26-000004 | 5722 | ||||||
| 2026-09-28 | 4 | xslF345X06/form4-09282026_040905.xml | 0002154450-26-000004 | 5734 | ||||||
| 2026-09-28 | 4 | xslF345X06/form4-09282026_040903.xml | 0002151480-26-000004 | 5701 | ||||||
| 2026-09-28 | 4 | xslF345X06/form4-09282026_040901.xml | 0001729510-26-000006 | 5675 | ||||||
| 2026-09-28 | 4 | xslF345X06/form4-09282026_040909.xml | 0002153534-26-000004 | 5731 | ||||||
| 2026-09-28 | 8-K | 8-K | 3.02,5.03,8.01,9.01 | 0001193125-26-405297 | 001-43482 | 261417172 | 34 | 193386 | 1 | 1 |
| 2026-09-28 | 424B4 | 424B4 | 0001193125-26-403094 | 333-298782 | 261411636 | 33 | 8511842 | |||
| 2026-09-24 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-003052 | 333-298782 | 261406085 | 33 | 1738 | ||
| 2026-09-24 | 3 | 3 | 0001193125-26-401301 | 161287 | ||||||
| 2026-09-24 | 3 | 3 | 0001193125-26-401300 | 161641 | ||||||
| 2026-09-24 | 3 | xslF345X06/ownership.xml | 0000947871-26-000882 | 21133 | ||||||
| 2026-09-24 | 3 | xslF345X06/form3-09242026_100906.xml | 0001231919-26-001226 | 16793 | ||||||
| 2026-09-24 | 3 | xslF345X06/form3-09242026_100932.xml | 0001967360-26-000011 | 10297 | ||||||
| 2026-09-24 | 3 | xslF345X06/form3-09242026_100905.xml | 0001323304-26-000004 | 11798 | ||||||
| 2026-09-24 | 3 | xslF345X06/form3-09242026_100928.xml | 0002153534-26-000002 | 10521 | ||||||
| 2026-09-24 | 3 | xslF345X06/form3-09242026_100931.xml | 0001706399-26-000002 | 15411 | ||||||
| 2026-09-24 | 3 | xslF345X06/form3-09242026_100929.xml | 0002153958-26-000002 | 22049 | ||||||
| 2026-09-24 | 3 | xslF345X06/form3-09242026_100936.xml | 0002154450-26-000002 | 14894 | ||||||
| 2026-09-24 | 3 | xslF345X06/form3-09242026_100938.xml | 0002151480-26-000002 | 10479 | ||||||
| 2026-09-24 | 3 | xslF345X06/form3-09242026_100945.xml | 0001282930-26-000014 | 20989 | ||||||
| 2026-09-24 | 3 | xslF345X06/form3-09242026_100933.xml | 0001729510-26-000004 | 33666 | ||||||
| 2026-09-24 | S-1MEF | S-1MEF | 0001193125-26-401133 | 333-299119 | 261405255 | 33 | 187144 | 1 | 1 | |
| 2026-09-24 | CERT | ADRX_8A_Cert_1802369.pdf | 0001354457-26-000906 | 001-43482 | 261404255 | 34 | 181051 | |||
| 2026-09-22 | 8-A12B | 8-A12B | 0001193125-26-397868 | 001-43482 | 261396844 | 34 | 14492 | |||
| 2026-09-21 | S-1/A | S-1/A | 0001193125-26-396007 | 333-298782 | 261392206 | 33 | 9495483 | 1 | 1 | |
| 2026-09-14 | S-1/A | S-1/A | 0001193125-26-390724 | 333-298782 | 261378124 | 33 | 8721648 | |||
| 2026-09-04 | S-1 | S-1 | 0001193125-26-383838 | 333-298782 | 261362879 | 33 | 9991720 | 1 | 1 | |
| 2026-07-31 | DRS/A | filename1.htm | 0001193125-26-328843 | 377-09495 | 261229461 | 33 | 9143071 | |||
| 2026-06-22 | DRS | filename1.htm | 0001193125-26-277710 | 377-09495 | 261108116 | 33 | 11337641 | |||
| 2023-08-10 | D | xslFormDX01/primary_doc.xml | 06b | 0001802369-23-000002 | 021-489353 | 231158541 | 33 | 13554 | ||
| 2023-01-26 | D | xslFormDX01/primary_doc.xml | 06b | 0001802369-23-000001 | 021-471878 | 23557373 | 33 | 11995 | ||
| 2021-08-17 | D | xslFormDX01/primary_doc.xml | 06b | 0001802369-21-000004 | 021-410307 | 211182681 | 33 | 11726 | ||
| 2021-05-24 | D | xslFormDX01/primary_doc.xml | 06b | 0001802369-21-000003 | 021-400299 | 21950637 | 33 | 10032 | ||
| 2020-11-17 | D | xslFormDX01/primary_doc.xml | 06b | 0001802369-20-000004 | 021-380734 | 201319070 | 33 | 10074 | ||
| 2020-08-07 | D | xslFormDX01/primary_doc.xml | 06b | 0001802369-20-000002 | 021-372735 | 201083561 | 33 | 9315 | ||
| 2020-02-06 | D | xslFormDX01/primary_doc.xml | 06b | 0001802369-20-000001 | 021-359900 | 20580574 | 33 | 6830 |
One latest value per concept from companyfacts (141 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 111.19M | 2026-11-06 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 58,236.72 | 2026-09-28 | S-8 | 2026-09-28 | 0001193125-26-405447 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 58,236.72 | 2026-09-28 | S-8 | 2026-09-28 | 0001193125-26-405447 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 421.70M | 2026-09-28 | S-8 | 2026-09-28 | 0001193125-26-405447 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-09-28 | S-8 | 2026-09-28 | 0001193125-26-405447 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-09-24 | S-1MEF | 2026-09-24 | 0001193125-26-401133 | |||
| us-gaap | AccountsAndFinancingReceivableAllowanceForCreditLoss | Accounts and Financing Receivable, Allowance for Credit Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 9.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 396,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 11.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 4.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 4.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -2.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 873.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions | APIC, Share-based Payment Arrangement, Recognition and Exercise | USD | 134,000 | 2025-01-01 | 2025-03-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 1.93M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 4,271 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 13.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | Assets | Assets | USD | 929.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 918.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 893.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 2.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 332.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 330.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 26,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 570.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 570.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 504.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 22.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 1000.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 107.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 107.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 11,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -80.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 330.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | USD | 2.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | DeferredIncomeNoncurrent | Deferred Income, Noncurrent | USD | 305.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 20.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 500,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercent | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay | pure | 0.5 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercentOfMatch | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | pure | 0.02 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage | Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage | pure | 0.04 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent | pure | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | Depreciation | Depreciation | USD | 920,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -6.46 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -6.46 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 135,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 4.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 2.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 66,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -5.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -1.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | -2.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | IncreaseDecreaseInPrepaidExpensesOther | Increase (Decrease) in Prepaid Expenses, Other | USD | 4.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | 11.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | InterestIncomeOperating | Interest Income, Operating | USD | 11.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | LeaseCost | Lease, Cost | USD | 2.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 7.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 556,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 2.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 2.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 2.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 901,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | Liabilities | Liabilities | USD | 354.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 929.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 43.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 502.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 78.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -76.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -76.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 12.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 94.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -89.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 1.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 6.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 1.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 4.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 1.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 6.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 1.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.082 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 100,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | 32,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -1.37M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -4.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | OtherLongTermDebtNoncurrent | Other Long-term Debt, Noncurrent | USD | 815,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 1.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 2.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 51.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 641,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 17.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 415.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 494.90M | 2026-09-28 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | ProceedsFromSaleMaturityAndCollectionsOfInvestments | Proceeds from Sale, Maturity and Collection of Investments | USD | 131.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 474,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 8.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 4.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 75.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -297.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 5.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 19.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 4.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.921 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.046 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 128.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 7.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 1.92 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 3.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 2.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 6.18 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 5.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 10.36 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 188.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 13.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 5.82 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 1.08 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 10.79 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 330.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 200,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 574.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 442,366 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 357.62M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 407.38M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 450,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 737,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 11.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 11.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458444 |